Non-medical switch from originator to biosimilar infliximab in patients with inflammatory arthritis: impact on s-infliximab and antidrug antibodies. Results from the Danish Rheumatological Biobank and the DANBIO registry

Bente Glintborg; Tina Marie Kringelbach; E. Høgdall; Inge Juul Sørensen; Dorte Vendelbo Jensen; A. G. Loft; O. Hendricks; I. M. J. Hansen; N. Bolstad; D. J. Warren; J. Gehin; G. Goll; Kathrine Lederballe Grøn; G. Eng; C. Enevold; C. H. Nielsen; J. S. Johansen; Merete Lund Hetland

Non-medical switch from originator to biosimilar infliximab in patients with inflammatory arthritis: impact on s-infliximab and antidrug antibodies. Results from the Danish Rheumatological Biobank and the DANBIO registry

Bente Glintborg, Tina Marie Kringelbach, E. Høgdall, Inge Juul Sørensen, Dorte Vendelbo Jensen, A. G. Loft, O. Hendricks, I. M. J. Hansen, N. Bolstad, D. J. Warren, J. Gehin, G. Goll, Kathrine Lederballe Grøn, G. Eng, C. Enevold, C. H. Nielsen, J. S. Johansen, Merete Lund Hetland

Afdeling for Rygkirurgi, Led- og Bindevævssygdomme

Originalsprog	Engelsk
Artikelnummer	OP10
Tidsskrift	Scandinavian Journal of Rheumatology
Vol/bind	45
Udgave nummer	Suppl. 128
Sider (fra-til)	6-7
Antal sider	2
ISSN	0300-9742
Status	Udgivet - 2016

Citationsformater

Glintborg, B., Kringelbach, T. M., Høgdall, E., Sørensen, I. J., Jensen, D. V., Loft, A. G., Hendricks, O., Hansen, I. M. J., Bolstad, N., Warren, D. J., Gehin, J., Goll, G., Grøn, K. L., Eng, G., Enevold, C., Nielsen, C. H., Johansen, J. S., & Hetland, M. L. (2016). Non-medical switch from originator to biosimilar infliximab in patients with inflammatory arthritis: impact on s-infliximab and antidrug antibodies. Results from the Danish Rheumatological Biobank and the DANBIO registry. Scandinavian Journal of Rheumatology, 45(Suppl. 128), 6-7. Artikel OP10.

Non-medical switch from originator to biosimilar infliximab in patients with inflammatory arthritis: impact on s-infliximab and antidrug antibodies. Results from the Danish Rheumatological Biobank and the DANBIO registry. / Glintborg, Bente; Kringelbach, Tina Marie; Høgdall, E. et al.
I: Scandinavian Journal of Rheumatology, Bind 45, Nr. Suppl. 128, OP10, 2016, s. 6-7.

Publikation: Bidrag til tidsskrift › Konferenceabstrakt i tidsskrift › Forskning › peer review

Glintborg, B, Kringelbach, TM, Høgdall, E, Sørensen, IJ , Jensen, DV, Loft, AG, Hendricks, O, Hansen, IMJ, Bolstad, N, Warren, DJ, Gehin, J, Goll, G, Grøn, KL, Eng, G, Enevold, C, Nielsen, CH, Johansen, JS & Hetland, ML 2016, 'Non-medical switch from originator to biosimilar infliximab in patients with inflammatory arthritis: impact on s-infliximab and antidrug antibodies. Results from the Danish Rheumatological Biobank and the DANBIO registry', Scandinavian Journal of Rheumatology, bind 45, nr. Suppl. 128, OP10, s. 6-7.

Glintborg B, Kringelbach TM, Høgdall E, Sørensen IJ , Jensen DV, Loft AG et al. Non-medical switch from originator to biosimilar infliximab in patients with inflammatory arthritis: impact on s-infliximab and antidrug antibodies. Results from the Danish Rheumatological Biobank and the DANBIO registry. Scandinavian Journal of Rheumatology. 2016;45(Suppl. 128):6-7. OP10.

@article{f3137374a9b14335a187d0ed6d9e2482,

title = "Non-medical switch from originator to biosimilar infliximab in patients with inflammatory arthritis: impact on s-infliximab and antidrug antibodies. Results from the Danish Rheumatological Biobank and the DANBIO registry",

author = "Bente Glintborg and Kringelbach, {Tina Marie} and E. H{\o}gdall and S{\o}rensen, {Inge Juul} and Jensen, {Dorte Vendelbo} and Loft, {A. G.} and O. Hendricks and Hansen, {I. M. J.} and N. Bolstad and Warren, {D. J.} and J. Gehin and G. Goll and Gr{\o}n, {Kathrine Lederballe} and G. Eng and C. Enevold and Nielsen, {C. H.} and Johansen, {J. S.} and Hetland, {Merete Lund}",

year = "2016",

language = "English",

volume = "45",

pages = "6--7",

journal = "Scandinavian Journal of Rheumatology",

issn = "0300-9742",

publisher = "Informa Healthcare",

number = "Suppl. 128",

}

TY - ABST

T1 - Non-medical switch from originator to biosimilar infliximab in patients with inflammatory arthritis: impact on s-infliximab and antidrug antibodies. Results from the Danish Rheumatological Biobank and the DANBIO registry

AU - Glintborg, Bente

AU - Kringelbach, Tina Marie

AU - Høgdall, E.

AU - Sørensen, Inge Juul

AU - Jensen, Dorte Vendelbo

AU - Loft, A. G.

AU - Hendricks, O.

AU - Hansen, I. M. J.

AU - Bolstad, N.

AU - Warren, D. J.

AU - Gehin, J.

AU - Goll, G.

AU - Grøn, Kathrine Lederballe

AU - Eng, G.

AU - Enevold, C.

AU - Nielsen, C. H.

AU - Johansen, J. S.

AU - Hetland, Merete Lund

PY - 2016

Y1 - 2016

M3 - Conference abstract in journal

SN - 0300-9742

VL - 45

SP - 6

EP - 7

JO - Scandinavian Journal of Rheumatology

JF - Scandinavian Journal of Rheumatology

IS - Suppl. 128

M1 - OP10

ER -